BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28625558)

  • 1. Irregular Defects in Hepatocellular Carcinomas During the Kupffer Phase of Contrast-Enhanced Ultrasonography with Perfluorobutane Microbubbles: Pathological Features and Metastatic Recurrence After Surgical Resection.
    Nuta J; Shingaki N; Ida Y; Shimizu R; Hayami S; Ueno M; Fukatsu K; Itonaga M; Yoshida T; Maeda Y; Moribata K; Deguchi H; Maekita T; Iguchi M; Kato J; Yamaue H; Tamai H
    Ultrasound Med Biol; 2017 Sep; 43(9):1829-1836. PubMed ID: 28625558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kupffer Imaging by Contrast-Enhanced Sonography With Perfluorobutane Microbubbles Is Associated With Outcomes After Radiofrequency Ablation of Hepatocellular Carcinoma.
    Nuta J; Tamai H; Mori Y; Shingaki N; Maeshima S; Shimizu R; Maeda Y; Moribata K; Niwa T; Deguchi H; Inoue I; Maekita T; Iguchi M; Kato J; Ichinose M
    J Ultrasound Med; 2016 Feb; 35(2):359-71. PubMed ID: 26782163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of Contrast-Enhanced Sonography With Perfluorobutane Microbubbles for Diagnosis of Recurrent Hepatocellular Carcinoma.
    Shagdarsuren B; Tamai H; Shingaki N; Mori Y; Maeshima S; Nuta J; Maeda Y; Moribata K; Niwa T; Deguchi H; Inoue I; Maekita T; Iguchi M; Kato J; Ichinose M
    J Ultrasound Med; 2016 Jul; 35(7):1383-91. PubMed ID: 27208196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of hepatocellular carcinoma by contrast-enhanced ultrasound with perfluorobutane microbubbles: comparison with dynamic CT.
    Mandai M; Koda M; Matono T; Nagahara T; Sugihara T; Ueki M; Ohyama K; Murawaki Y
    Br J Radiol; 2011 Jun; 84(1002):499-507. PubMed ID: 20959373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfluorobutane-enhanced ultrasonography with a Kupffer phase: improved diagnostic sensitivity for hepatocellular carcinoma.
    Hwang JA; Jeong WK; Kang HJ; Lee ES; Park HJ; Lee JM
    Eur Radiol; 2022 Dec; 32(12):8507-8517. PubMed ID: 35705829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Value of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Early Recurrence of Hepatocellular Carcinoma after Surgical Resection.
    Wang Y; Liao J; Qi W; Xie L; Li Y
    Ultrasound Med Biol; 2016 May; 42(5):1042-8. PubMed ID: 26803390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced US with Perfluorobutane for Hepatocellular Carcinoma Surveillance: A Multicenter Diagnostic Trial (SCAN).
    Park JH; Park MS; Lee SJ; Jeong WK; Lee JY; Park MJ; Lee SS; Han K; Nam CM; Park SH; Lee KH
    Radiology; 2019 Sep; 292(3):638-646. PubMed ID: 31287387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of contrast-enhanced ultrasound with perflubutane for diagnosing the macroscopic type of small nodular hepatocellular carcinomas.
    Tada T; Kumada T; Toyoda H; Ito T; Sone Y; Kaneoka Y; Maeda A; Okuda S; Otobe K; Takahashi K
    Eur Radiol; 2014 Sep; 24(9):2157-66. PubMed ID: 24952601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced patterns on intraoperative contrast-enhanced ultrasonography predict outcomes after curative liver resection in patients with hepatocellular carcinoma.
    Nakamura I; Hatano E; Tada M; Kawabata Y; Tamagawa S; Kurimoto A; Iwama H; Toriguchi K; Sueoka H; Iida K; Yoshida M; Nishimura T; Iijima H
    Surg Today; 2021 May; 51(5):764-776. PubMed ID: 32964250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of post-vascular phase (Kupffer imaging) by contrast-enhanced ultrasonography using Sonazoid in the detection of hepatocellular carcinoma.
    Goto E; Masuzaki R; Tateishi R; Kondo Y; Imamura J; Goto T; Ikeda H; Akahane M; Shiina S; Omata M; Yoshida H; Koike K
    J Gastroenterol; 2012 Apr; 47(4):477-85. PubMed ID: 22200940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma.
    Takahashi M; Maruyama H; Ishibashi H; Yoshikawa M; Yokosuka O
    AJR Am J Roentgenol; 2011 Feb; 196(2):W123-31. PubMed ID: 21257852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High Risk.
    Kang HJ; Lee JM; Yoon JH; Lee K; Kim H; Han JK
    Radiology; 2020 Oct; 297(1):108-116. PubMed ID: 32749211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Value of Contrast-enhanced Ultrasound for Early Recurrence of Single Lesion Hepatocellular Carcinoma After Curative Resection.
    Xiachuan Q; Xiang Z; Xuebing L; Yan L
    Ultrason Imaging; 2019 Jan; 41(1):49-58. PubMed ID: 30803409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound.
    Chen LD; Ruan SM; Liang JY; Yang Z; Shen SL; Huang Y; Li W; Wang Z; Xie XY; Lu MD; Kuang M; Wang W
    World J Gastroenterol; 2018 Sep; 24(33):3786-3798. PubMed ID: 30197484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of Contrast-enhanced Ultrasonography with Perflubutane for Determining Histologic Grade in Hepatocellular Carcinoma.
    Tada T; Kumada T; Toyoda H; Ito T; Sone Y; Kaneoka Y; Maeda A; Okuda S; Otobe K; Takahashi K
    Ultrasound Med Biol; 2015 Dec; 41(12):3070-8. PubMed ID: 26360976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced ultrasound features of histologically proven small (≤20 mm) liver metastases.
    Dong Y; Zhang XL; Mao F; Huang BJ; Si Q; Wang WP
    Scand J Gastroenterol; 2017 Jan; 52(1):23-28. PubMed ID: 27577113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma in otherwise sonographically normal liver.
    Naganuma H; Ishida H; Ogawa M; Sato T; Sageshima M; Suzuki K; Ohyama Y
    J Clin Ultrasound; 2019 Jul; 47(6):325-330. PubMed ID: 30484875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity-Based Assessment of Microbubble-Enhanced Ultrasonography: Phase-Related Diagnostic Ability for Cellular Differentiation of Hepatocellular Carcinoma.
    Kondo T; Maruyama H; Kiyono S; Sekimoto T; Shimada T; Takahashi M; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Chiba T; Kanai F; Yokosuka O
    Ultrasound Med Biol; 2015 Dec; 41(12):3079-87. PubMed ID: 26371403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of contrast-enhanced ultrasound with Perfluorobutane in lesion detection, guidance for microwave ablation, and response assessment of hepatocellular carcinoma.
    Mukund A; Bansal A; Patidar Y; Thapar S; Sharma MK; Sarin SK
    Abdom Radiol (NY); 2022 Oct; 47(10):3459-3467. PubMed ID: 35842563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced sonography-guided radiofrequency ablation for the local recurrence of previously treated hepatocellular carcinoma undetected by B-mode sonography.
    Miyamoto N; Hiramatsu K; Tsuchiya K; Sato Y
    J Clin Ultrasound; 2010 Sep; 38(7):339-45. PubMed ID: 20572066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.